Home › Research › Disparities
Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors
Catindig JA, Venketasubramanian N, Ikram MK, Chen C.. Journal of the neurological sciences, 2012-08-09
Topic: Risk, prevention and care in population studies
Plain-language summary
Asia is the most populous region in the world and its rapidly growing societies are the sources of global development. However, accompanying this rapid growth is aging of the population with increasing occurrence of diseases, of which dementia is the most prominent, which provide major challenges to healthcare systems. Dementia prevalence in Asia has previously been found to be lower than Western populations, but recent studies show that age-specific prevalence rates are similar globally. Overall dementia prevalence is expected to rise dramatically across Asia due to maturing populations. Earlier Asian studies reported a lower prevalence of Alzheimer's disease (AD) and a higher prevalence of vascular dementia (VaD). Recent studies, however, show a reversal of this ratio that now parallels that of Western countries. This change may be attributed to an altered demographic profile, urbanization, environmental reactions, ethnicity and advances in the use of neuroimaging modalities. Several factors may influence the results of epidemiological studies including changes in societal perception of aging, family attitudes, validity of assessment tools due to language and literacy, and medical practitioners' expertise in recognizing dementia. Nevertheless, epidemiological studies in Asia may reveal factors contributory to inter-ethnic differences in dementia. Potentially modifiable risk factors apparent only in low and middle-income countries and gene-environment interactions may underlie these disparities and identification of such factors may lead to effective treatments.
What this study adds
Evidence grade: Low
This is a narrative review. This review describes dementia prevalence and trends in Asia, noting that overall prevalence is expected to rise dramatically as populations age and that the ratio of Alzheimer's disease to vascular dementia has shifted to resemble Western countries. It discusses possible risk factors but does not test any treatment, cure, or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Catindig, J. A., Venketasubramanian, N., Ikram, M. K., & Chen, C. (2012). Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors. Journal of the neurological sciences. https://doi.org/10.1016/j.jns.2012.07.023
Vancouver
Catindig JA, Venketasubramanian N, Ikram MK, Chen C. Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors. Journal of the neurological sciences. 2012. doi:10.1016/j.jns.2012.07.023. PMID: 22877510.
BibTeX
@article{catindig2012-22877510,
author = {Catindig, J. A. and Venketasubramanian, N. and Ikram, M. K. and Chen, C.},
title = {{Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors}},
journal = {Journal of the neurological sciences},
year = {2012},
doi = {10.1016/j.jns.2012.07.023},
pmid = {22877510},
url = {https://doi.org/10.1016/j.jns.2012.07.023}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Overall dementia prevalence is expected to rise dramatically across Asia due to maturing populations.
- Several factors may influence the results of epidemiological studies including changes in societal perception of aging, family attitudes, validity of assessment tools due to language and literacy, and medical practitioners' expertise in recognizing dementia.
Why it matters
This review describes dementia prevalence and trends in Asia, noting that overall prevalence is expected to rise dramatically as populations age and that the ratio of Alzheimer's disease to vascular dementia has shifted to resemble Western countries. It discusses possible risk factors but does not test any treatment, cure, or prevention.
New to this subject? Start with our plain-English guide: Disparities →
Study details
- Evidence strengthLow
How this study scored 44/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of the neurological sciences) |
| Journal's citation record | 2 / 4 | Journal of the Neurological Sciences: journal h-index 233 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2012 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 144 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 9.0 citations a year over 16 year(s) since 2012 |
| Impact for its field and year | 3 / 6 | Cited 6.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 8 other studies in this library |
| Still being cited | 2 / 4 | Cited 37 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Christopher Chen: h-index 90 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Erasmus MC: institution h-index 1,321 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 6 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 22877510) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 44 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
8 studies in the alzhub library list this one in their references.
Related studies in Disparities from nearby years
Also tagged “prevalence”
1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.